EGA
VCYT icon

Eagle Global Advisors’s Veracyte VCYT Stock Holding History

Eagle Global Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,410
Closed -$337K – 361
2017
Q2 		$337K Buy
40,410
+27,460
+212% +$224K 0.01% 282
2017
Q1 		$119K Buy
+12,950
New +$106K ﹤0.01% 370

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eagle Global Advisors's VCYT Position: Q3 2017 in Review

Eagle Global Advisors sold out of Veracyte (VCYT) in Q3 2017, closing a stake of 40,410 shares — an estimated $337K sold.

Eagle Global Advisors first reported a position in VCYT in Q1 2017 and held it in 2 quarters. The position peaked at $337K in Q2 2017. 87 funds tracked by Wall St. Rank hold VCYT as of Q3 2017.

  • Eagle Global Advisors reported no remaining Veracyte position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 40,410 Veracyte shares in Q3 2017, an estimated $337K.
  • Eagle Global Advisors first reported a position in Veracyte in Q1 2017 and held it in 2 quarters.
  • Eagle Global Advisors's Veracyte position peaked at $337K in Q2 2017.
  • 87 funds tracked by Wall St. Rank held Veracyte as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.